chrisvoncsefalvay/vaers-outcomes huggingface dataset:
magnetism at the shot site; Confirmed diagnosis of COVID-19; Confirmed diagnosis of COVID-19; flu-like symptoms; This is a spontaneous report from a contactable consumer (patient). This report was received via a sales representative. A patient of unspecified age and gender received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as dose number unknown, single for covid-19 immunisation. Patient had no underlying medical conditions. The patient's concomitant medications were not reported. The patient was vaccinated as of early summer. Patient experienced flu-like symptoms for 3 days following the vaccination. Patient experienced magnetism at the shot site. Patient had confirmed diagnosis of COVID-19 on 04Oct2021. The outcome of the events was unknown.  The lot number for BNT162B2, was not provided and will be requested during follow up.
Narrative: Patient reported reaction as worsening SOB, dizziness and feeling drugged on the second day after vaccination. He reported that the reaction has subsided. Pt received second dose upon instructions from cardiologist, PT had the same reaction the next day.
Red, warm, raised area to direct injection site measuring 8 cm width by 4 cm height 1 day following injection
The caller already took the first dose and tested positive.; The caller already took the first dose and tested positive.; This is a spontaneous report received from a contactable consumer (patient) via a Pfizer-sponsored program. A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection; lot number: Not reported), via an unspecified route of administration on an unknown date at single dose for COVID-19 immunization. It was reported that, the patient already took the first dose and tested positive on an unknown date. The outcome of the events was reported as unknown.  Information on the lot/batch number has been requested.
I believe this vaccination adversely affected my kidneys.  the day after the injection I was drinking lots of water to help overcome the side effects (flu like symptoms) and was not using the bathroom very much and when I did, very little urine would come out.  very tired, I went to sleep around 8 PM and by 11 PM woke up because I needed to urinate.   several times that night I urinated after waking up with a very full Blatter.  this tells me that my kidneys may have been negatively affected and once the flue like systems started to subside the kidneys were returning to normal and clearing out the excess water my body had taken in during the day.
Discharge Provider Primary Care Provider Admission Date: 3/24/2023 Discharge Date: 03/25/2023 Admitting Diagnoses: Active Problems:   COVID  HOSPITAL COURSE: Patient is a 60 y.o. female with h/o metastatic ovarian adenocarcinoma, chemotherapy-associated neuropathy, HTN, hypothyroidism, anxiety/depression, narcolepsy, OSA and obesity, presented to the ER with c/o fever, sore throat, cough and myalgias. Symptoms present and progressive over the past 2-3 days, attributed to COVID due to recent sick contacts. In the ER, she was febrile, hypertensive, tachycardic, and mildly tachypnic, saturating in the mid-90's on room air alone.  Viral screen was COVID positive. Patient felt improved on supportive care and was walked by nursing without oxygen desaturation. Blood pressure also improved back to baseline and patient requested discharged on 3/25.    Close follow up advised as noted below including following up with primary care provider. Patient expressed understanding and agreement with this plan. Patient in agreement with and requested discharge on 03/25/2023
This spontaneous report was received from a Licensed Practical Nurse referring to a patient of unknown age and gender. The patient's medical history, concurrent conditions, concomitant medications, and historical drugs were not reported. On 16-FEB-2018, the patient was vaccinated with an improperly stored dose of Oka-Merck PROQUAD with lot # N023967 (expiration date unknown)(Strength, route, dose, frequency, and anatomical location were unknown) for prophylaxis reconstituted with MERCK STERILE DILUENT that was properly stored. There was no adverse effect reported. The administered dose of vaccine experienced the temperature excursion of 6°F to 14°F degrees Fahrenheit for 158 hours 39 minutes and 15°F to 46°F degrees Fahrenheit for 343 hours 29 minutes. There was a digital data logger involved, but there was no previous temperature excursion. This is one of several reports received from the same reporter. Sender's Comments: US-009507513-1803USA006483.
Mom describes Erythema and warmth at injection site that began - 24 hrs after injection. It's size increase to baseball size of a hard induration under skin with 4x3 inch Erythema around injection site. Resolving completely as of today 9/25/08. Pt not seen in office at the time
Redness noted immediately after vaccines given and bandaids applied with approximately 3 to 4 cm to upper left arm site and approximately 2cm to left thigh site and after approximately 50 minutes no redness seen with mild puffiness to left upper arm.  No treatment given.
2 HOURS POST #1 VACCINE I STARTED TO HAVE SOME CARDIAC ARRHYTHMIA WHICH RESOLVED LATER THAN EVENING and reoccured sporadically day 1 by the evening of day 2  evening +-48 hrs post tax the arrhythmia feelings came back and didn't go away and seemed to be getting worse so I went to the ER.
I am currently 24 weeks pregnant . I received my first dose at 14 weeks and my second dose at 19 weeks. I went to see my OBGYN because I had trouble breathing, asthma and I am also pregnant.  My doctor started prescribe me asthma inhaler.  Baby is doing good.  I am still using inhalers for my asthma and being monitored by my OBGYN.
Started as just a little nausea.  By 9:30 pm I felt quite sick to my stomach.  By 10:30 PM I began vomiting with pretty intense stomach pain, spiked a fever of 101.2 at it highest, body aches.  I continued to vomit until approximately 2 am.  From that point on, the fever remained until approximately noon the next day. The nausea and body aches did not go away until approximately 6pm the next day.
97 Pt recv 1 dose vax SC. 6Jan98 pt exp chickenpox. One of the pt sibling had similar exp (WAES98010739).
3/26/02 Headache, myalgia, low grade fever. 3/27/03 Felt better. 4/2/03 Fever 101.4, severe headache, myalgia. 4/3/03 ER visit - received medicine for severe headache; went home with PO Lortab. 4/8/03 Severe headache, neck pain, head pounding, photophobia; ER visit - admitted to hospital.
after being awake for 15 minutes I got up from being seated-immediately blacked out and fell hitting my head on the floor
Pt has colic, @ 1 mo of age recvd DTP/HIB; Also apparently recvd some DT but unk amount; pt devel colic shortly thereafter;
presents with brain fog, confusion, echolalia, expresive aphasia  diagnosed with  NMDA autoimmune encephalitis by spinal tap
Information has been received from a 64 year old female Registered nurse, reporting on herself, with no pertinent medical history, no drug reactions or allergies, who in approximately 2008, about 2-3 years ago, was vaccinated with a dose of ZOSTAVAX (Merck) (Lot #, dose and route not reported). There were no concomitant medications reported. Registered nurse reported that in March 2011, she developed a case of shingles. She described the shingles as a painful rash that started under her right breast and extended around to her back. Registered nurse reported that the shingles was painful to touch, and she did not move for a week (date unspecified). Registered nurse also reported that a week after the rash developed, she saw her physician, who treated her with an unspecified antiviral medication and LYRICA for a week, and the symptoms resolved. Registered nurse stated that she was now fully recovered. The case of shingles and did not move for a week were considered to be disabling by the registered nurse. No further information is available.
Joint pain; Headache; This spontaneous case was reported by a consumer and describes the occurrence of ARTHRALGIA (Joint pain) and HEADACHE (Headache) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Feb-2021, the patient experienced ARTHRALGIA (Joint pain) and HEADACHE (Headache). At the time of the report, ARTHRALGIA (Joint pain) and HEADACHE (Headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. Treatment information was not provided.; Sender's Comments: Based on the current available information and temporal association between the use of mRNA-1273 and the onset of the events, a causal relationship cannot be excluded. The reported events are consistent with the product safety profile
In the days and weeks after receiving the Moderna vaccine, I had a variety of headaches as follows: Shooting pains in the back of my head on the right side and behind my ear; pain on the right front side of my head, usually while sleeping and waking up from the pain; one episode of waking up with pain on the left side of my head, temple, teeth and side. The headaches continue to this day, March 10, 2021, one month after receiving the vaccine. I reported the headaches to my GP, but he advised me to still get the second dose, scheduled for March 13, 2012. I am cancelling that appointment because of the headaches.
fever that is "on and off"; headache that is "on and off"; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (fever that is "on and off") and HEADACHE (headache that is "on and off") in a 36-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 011A21A and 011A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 09-Mar-2021, the patient experienced PYREXIA (fever that is "on and off") and HEADACHE (headache that is "on and off"). The patient was treated with IBUPROFEN (MOTRIN [IBUPROFEN]) at an unspecified dose and frequency. At the time of the report, PYREXIA (fever that is "on and off") and HEADACHE (headache that is "on and off") outcome was unknown. Not Provided          No concomitant medications were provided. Action taken with mRNA-1273 in response to the event was not applicable.   This case was linked to US-MODERNATX, INC.-MOD-2021-076822 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-076822:first dose
Quarter sized area of erythema containing some papules, but no induration. Child fussy, without other systemic symptoms. Treatment only with topical Diphenhydramine PRN.
Covid symptoms started on 03/24/2022, tested positive on 03/26/2022. I had a sore throat and a cough and those were the most prominent symptoms. I also had fatigue and body aches more than normal. That lasted for 5 days and then went away, and then it came back. 9 days into it I started having difficulty with shortness of breath and I went into the ER and they gave me an albuterol inhaler and otherwise I didn't really take too much other medications but I did sleep a lot. Symptoms lasted about 3 weeks. I still have body aches and an occasional cough and fatigue.
Febrile seizure lasting < 2 minutes.  Post ictal for several hours w/o lateralizing features.
The FLULAVAL QUADRIVALENT vaccine that was administered was stored outside of the expected temperature range (36-46F) for 96 hours with a maximum temperature reaching 51.8F. The manufacturer, has reported that the product is not valid/inactive if stored in temperatures above 46F for more than 72 hours. Per CDC recommendations, the employee will need to be re-vaccinated and may receive immediately, no need to wait. Employee notified of event and will schedule to be re-vaccinated.
Initial report received from a health care professional on 25 April 2011. A male patient, with no medical history reported, received on 23 October 2008 a left deltoid intramuscular injection of FLUZONE, lot number U2802AA. The patient had received doses of influenza vaccine prior to 2008 and doses after 2008. On an unknown date the patient developed a sore lump 3 inches below the injection site from the influenza vaccine that was given in 2008 on his left arm. The outcome was reported as not recovered. Documents held by sender: None.
PATIENT CAME IN TO GET HER 2ND BOOSTER SHOT OF THE PFIZER COVID19 VACCINE.  SHE WAS ANXIOUS UPON ARRIVAL BUT FILLED OUT CONSENT FORMS AND WANTED TO GET HER BOOSTER.  SHE WAITED IN THE STORE FOR AT LEAST 15 MINUTES AFTER HER SHOT.  ABOUT 45 MINUTES LATER SHE CALLED TO REPORT THAT HER TONGUE WAS SWELLING BUT WAS STILL ABLE TO TALK AND BREATH.  WE INSTRUCTED HER TO GO TO THE EMERGECY DEPARTMENT.
First shot was just as said it would be, next day I would feel as if getting the flu or a cold. After to days I was good. Second shot wasn't right. Next day.chest was heavy stomach up set dizzy, then the migrain s started. Dont want to eat, just feel ill all the time. Chest, sometimes is hard to breath, sometimes I think I'm going to have a heart ache it will hurt so bad. I Don't have energy to do anything, no interest in doing anything.  Sleep is a joke anymore. Joints ache, headaches. IT'S been FOUR MONTHS now,. When will this go away?
Patient left the clinic and developed itching in throat with in four hours post vaccine, was taken to the emergency room for treatment, given benadryl.
ache: joints and muscles, mood: anxiety, arthritis, asthma, balance: dizziness, blood: high cholesterol, chills, constipation, joints: ache, lesion: left eye (lachrymal gland, neurological disorientation and confusion, mood: irritable, mood: angry, mood: anxious, nervousness(anxiety), sleep: insomnia, sleep: shifting sleep patterns, sleep: unable to sleep flat without medication, thirst: increased, tinnitus, depression, urinary frequency, vision: poor tolerance for bright lights, voice alteration, weight gain, weakness, verbal skills: trouble finding words.  MR received from May 2003 to July 2006 with consults for psychiatry, PM&R, surgery (inguinal hernia), ophthalmology, ENT, and audiology for the following diagnoses: :low back pain since 1983 and shoulder pain since 1997 treated with multiple rounds of PT. :hyperlipidemia :suspected hearing loss and tinnitus-Audiology eval WNL (12/2003) :bronchial asthma :hemorrhoids Psych evals (09/2005) with Dx. of PTSD x 2 tours overseas, insomnia, and depression.
4th day after dose 2, pain under right side ribs, as days progressed, pain circled around back to right side.  severally limited mobility. lasted about 8 days, then tapered down to much milder pain.; 4th day after dose 2, pain under right side ribs, as days progressed, pain circled around back to right side.  severally limited mobility. lasted about 8 days, then tapered down to much milder pain.; circled around back to right side.  severally limited mobility. lasted about 8 days, then tapered down to much milder pain.; This is a spontaneous report from a contactable consumer (patient). A 77-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot Number: EL3249), via an unspecified route of administration, administered in Left arm on 26Jan2021 13:00 at the age of 77-years-old as 2nd dose, single dose for covid-19 immunisation. Medical history included CHF (Congestive heart failure) from an unknown date and unknown if ongoing, PE (pulmonary embolism) from an unknown date and unknown if ongoing. The patient had no known allergies. Concomitant medications included unspecified medication, Allioyrubikm; Dabigatran (DABIGATRAN) taken for an unspecified indication, metoprolol (METOPROLOL) taken for an unspecified indication, spironolactone (SPIRONOLACTONE) taken for an unspecified indication on unspecified date received in two weeks of vaccination. The patient previously took first dose of historical vaccine, bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot Number: EK5730), via an unspecified route of administration, administered in Left arm on 05Jan2021 at 13:00 as single dose for covid-19 immunisation. The patient did not receive other vaccine in four weeks of vaccination. The patient was not diagnosed with COVID-19 prior vaccination. The patient has not been tested for COVID-19 post vaccination. Covid test post vaccination was no. On 29Jan2021 at 06:00, 4th day after dose 2 the patient experienced pain under right side ribs, as days progressed, pain circled around back to right side. severally limited mobility. lasted about 8 days, then tapered down to much milder pain. still have pain 10 days after dose 2. No treatment was received for adverse events. The outcome of event, mobility decreased was unknown and for other events was not recovered.  Follow-up (07MAY2021): Follow-up attempts completed. No further information expected.
Adverse reaction to dose 1 of Pfizer COVID-19 vaccine (lot# EN6207). Pt was vaccinated at 1735 and reported itchiness on arms, chest, and scalp at 1800. Immediate area around the vaccination (right deltoid) was not erythematous but PT's arms and chest had flat, erythematous patches. PT has a Hx of formaldehyde allergy (hives and itchiness). Denied SOB, swelling, or tingling in lips/tongue/mouth. Denied lightheadedness or racing heartbeat. Monitored PT for the remainder of her 30-minute observation period. Recommended that she call 911 if she experiences any of the aforementioned symptoms, and that she can take Benadryl when she returns home.
A pharmacy student reported that a 47 year old male received an injection of Flu Shield ('00-'01) on 12/12/00. On 1/7/01, the pt was hospitalized with elevated phenytoin (33 mcg/mL) and phenobarbital levels (no value provided).
Administered the vaccine below the deltoid or at the end of the deltoid; Symptoms are as if got the flu shot; Warm; Hard; Tired; Red area on arm the size of a quarter; Headache; A spontaneous report was received from a nurse who is a 70-year-old, white female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced administered vaccine below the deltoid or at the bottom of the deltoid/incorrect route of product administration, tired/fatigue, headache, red area on arm the size of a quarter/injection site erythema, warm/injection site warmth and hard/injection site induration, and symptoms are as if got the flu shot/influenza like illness.  The patient's medical history was not provided. No concomitant medications were reported.  On 11 Feb 2021, the patient received their first of two planned doses of mRNA-1273 (Lot number: 026L20A) in the right arm intramuscularly for prophylaxis of COVID-19 infection.   On 11 Feb 2021, the patient reported, the Moderna COVID-19 vaccine was administered below the deltoid or at the end of the deltoid. The patient also reported she was tired and had a headache and there was a red, warm and hard area the size of a quarter on her arm. She stated, her symptoms were like that of when she received the flu vaccine.   Treatment information was not provided.  Action taken with mRNA-1273 in response to the events was not provided.   The outcome of the event, administered vaccine below the deltoid or at the bottom of the deltoid/incorrect route of product administration, was considered resolved on 11 Feb 2021.  The outcome of the events, tired/fatigue, headache, red area on arm the size of a quarter/injection site erythema, warm/injection site warmth and hard/injection site induration, and symptoms are as if got the flu shot/influenza like illness, were considered unknown.; Reporter's Comments: This is a case of 70--year-old, female patient who was administered mRNA-1273 and experienced below the deltoid or at the bottom of the deltoid (vaccine administered at inappropriate site) Lot # BATCH # 026L20A. The other events temporarily association with product and a causal relationship cannot be excluded.
No adverse event; Vaccine administered after beyond use date 07-Jul-2022; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine administered after beyond use date 07-Jul-2022) and NO ADVERSE EVENT (No adverse event) in a 2-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. AS1414B) for COVID-19 prophylaxis.     No Medical History information was reported.    On 21-Jul-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Jul-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine administered after beyond use date 07-Jul-2022). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Vaccine administered after beyond use date 07-Jul-2022) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Vaccine administered after beyond use date 07-Jul-2022).    No concomitant medication was reported.  The vaccine received date was 07-Jun-2022 and beyond use date was 07-Jul -2022.  No treatment information was provided.
This spontaneous report was received from a registered nurse and refers to a 4 year old male patient. The patient's concurrent conditions, medical history and concomitant therapies were not reported. The stock of vaccine was received on 11-OCT-2016. On 05-DEC-2016, the patient was vaccinated with an improperly stored dose of PROQUAD, lot # M023931 with expiration date of 09-NOV-2017 (dose, route and frequency were not reported) for prophylaxis. It was stated that the vaccine underwent a temperature excursion of 6 degrees Fahrenheit to 14 degrees Fahrenheit for 55 days. It was reported that there was no need to repeat vaccine. This is one of the several reports received from the same reporter. Sender's Comments: US-009507513-1705USA013888.
Received flu shot in arm and began developing hives on lower extremities.  Pt also reported on ER note that she has egg allergy.  Pt had taken Benadryl 50mg at home but still had hives.  Pt was evaluated and treated with Decadron for urticaria in ER on 17Feb17.
Patient states day after receiving vaccine, she began to develop mild flu symptoms (fever, chills, etc.)  that persisted and progressively gotten worse throughout the week. She reported still being sick as of 8/26/19.